Cargando…
Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719386/ https://www.ncbi.nlm.nih.gov/pubmed/34972523 http://dx.doi.org/10.1186/s13020-021-00551-x |
_version_ | 1784624926368464896 |
---|---|
author | Qin, Gaofeng Dong, Yunfang Liu, Zhenhong Gong, Zhuoyan Gao, Chenyan Zheng, Mingcui Tian, Meijing He, Yannan Zhong, Liqun Wang, Pengwen |
author_facet | Qin, Gaofeng Dong, Yunfang Liu, Zhenhong Gong, Zhuoyan Gao, Chenyan Zheng, Mingcui Tian, Meijing He, Yannan Zhong, Liqun Wang, Pengwen |
author_sort | Qin, Gaofeng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8719386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87193862022-01-05 Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro Qin, Gaofeng Dong, Yunfang Liu, Zhenhong Gong, Zhuoyan Gao, Chenyan Zheng, Mingcui Tian, Meijing He, Yannan Zhong, Liqun Wang, Pengwen Chin Med Correction BioMed Central 2021-12-31 /pmc/articles/PMC8719386/ /pubmed/34972523 http://dx.doi.org/10.1186/s13020-021-00551-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Qin, Gaofeng Dong, Yunfang Liu, Zhenhong Gong, Zhuoyan Gao, Chenyan Zheng, Mingcui Tian, Meijing He, Yannan Zhong, Liqun Wang, Pengwen Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro |
title | Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro |
title_full | Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro |
title_fullStr | Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro |
title_full_unstemmed | Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro |
title_short | Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro |
title_sort | correction to: shen-zhi-ling oral liquid ameliorates cerebral glucose metabolism disorder in early ad via insulin signal transduction pathway in vivo and in vitro |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719386/ https://www.ncbi.nlm.nih.gov/pubmed/34972523 http://dx.doi.org/10.1186/s13020-021-00551-x |
work_keys_str_mv | AT qingaofeng correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT dongyunfang correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT liuzhenhong correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT gongzhuoyan correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT gaochenyan correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT zhengmingcui correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT tianmeijing correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT heyannan correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT zhongliqun correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro AT wangpengwen correctiontoshenzhilingoralliquidamelioratescerebralglucosemetabolismdisorderinearlyadviainsulinsignaltransductionpathwayinvivoandinvitro |